Region — International. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Vallydia
ExploreShopToolsJournalTrust
Explore  /  Climbazole
Research reference — not for sale

Climbazole

C
lead outcome
Topical (scalp, rinse-off): visible flaking…
grades vary by outcome ↓
Small molecule (non-peptide)
also called — climbazol
antidandruffscalp (cosmetic)preservative
In brief

An azole antifungal used in anti-dandruff shampoos, and one of the actives that absorbed the European market after zinc pyrithione was prohibited in 2022. Formulations containing it control visible flaking effectively, including one that matched a 1% zinc pyrithione product in a split-head comparison. Two qualifications matter more than usual here. No published trial has tested climbazole on its own, so every result attributed to it came from a shampoo containing a second antifungal. And the largest relevant trial, in 620 people, set out to compare the two ways of making a shampoo stronger, adding a second active or improving delivery of one, and found that the zinc pyrithione plus climbazole product was beaten at every weekly timepoint by the single-active formulation with better bioavailability. Read that as evidence about how shampoos are built rather than proof that this molecule fails, and read the dual-active marketing with more suspicion than the shelf invites.

Legal standing, by region
European Union
Lawful cosmetic ingredient, subject to concentration limits

Lawful in the EU under Regulation (EC) No 1223/2009, at maximum concentrations that differ by product type and by the job the ingredient is doing. Commission Regulation (EU) 2019/698 set the current position: as an anti-dandruff active it is permitted only in rinse-off shampoo, at up to 2.0% (Annex III, entry 310); as a preservative it is restricted to four categories under Annex V, entry 32 — rinse-off shampoo at up to 0.5%, and hair lotions, face creams and foot care products at up to 0.2%. That 2019 amendment narrowed preservative use, which had previously been allowed across cosmetic products generally. It was unaffected by Commission Regulation (EU) 2021/1902, which prohibited zinc pyrithione in cosmetics from 1 March 2022, and it is one of the actives that absorbed the European anti-dandruff market as a result.

United States
Used as a cosmetic ingredient

Used in the United States as a conventional cosmetic ingredient. It does not hold the over-the-counter anti-dandruff monograph status that zinc pyrithione holds there, so it appears less often in American anti-dandruff products than in European ones.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Topical (scalp, rinse-off): visible flaking control, in combination formulations
Two limitations compound each other. The active has not been tested alone in this literature, so its individual contribution is unresolved. And in the largest of the three trials the zinc pyrithione plus climbazole product was beaten by an optimised single-active formulation at every weekly timepoint.
Three randomised trials, in every case testing climbazole as one of two actives: with piroctone olamine against zinc pyrithione in a split-head study (Schmidt-Rose 2011), and twice paired with zinc pyrithione (Turner 2012; Schwartz 2013, a double-blind trial in 620 participants). · Formulations containing climbazole reduced visible flaking effectively across these trials, and in the split-head comparison a piroctone olamine and climbazole shampoo matched a 1% zinc pyrithione product.
C
Marketing claim: a second active makes an anti-dandruff shampoo more effective
This compares formulations rather than molecules, and it does not show that climbazole is inert. It does undercut the specific proposition that two actives are better than one, which is how dual-active shampoos are sold.
The premise was tested directly in a randomised double-blind trial of 620 participants comparing the two strategies against each other: adding a second active, or maximising the bioavailability of one (Schwartz 2013). · The single-active formulation with optimised delivery outperformed the dual-active product containing climbazole on both flaking and epidermal histamine, at all four weekly assessments, and delivered more active to the target region of the follicle.
D
Attributed to climbazole as a single active
This is not evidence of absence, and the mechanism is a reasonable one. It means the confident single-ingredient claims made for climbazole rest on trials that were never designed to support them.
No trial in the available literature isolates climbazole against a vehicle or a comparator on its own. · Unresolved. Every efficacy result attributed to this ingredient was produced by a formulation containing at least one other antifungal active.
D
Safety (topical, rinse-off, at cosmetic use levels)
As an azole it is subject to concentration limits by product type rather than being unrestricted, and those limits differ between rinse-off and leave-on use.
Established lawful cosmetic use in anti-dandruff and preservative roles, within the concentration limits applicable in each market. · Well tolerated in rinse-off scalp products at the levels used.
—
Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Climbazole changes - nothing else.

One ingredient, one purpose. No marketing, no sharing. Unsubscribe anytime. See our privacy policy.

Cosmetic claims boundary
✓ Allowed (appearance / feel)
  • helps reduce visible flakes as part of an anti-dandruff formulation
  • helps the scalp feel comfortable
  • an antifungal active used in European anti-dandruff shampoos
✕ Not allowed (medicinal)
  • treats seborrhoeic dermatitis
  • cures dandruff
  • proven more effective than zinc pyrithione
  • two actives work better than one

The medicinal-sounding science stays in the reference section; product copy speaks only to appearance/feel (Reg 655/2013). Different fields, never merged.

The honest part

Two separate problems sit under this ingredient's reputation. The first is that no published trial has tested it on its own, so every figure quoted for it belongs to a formulation containing something else. The second is sharper: the one large trial that set out to test whether a second active helps at all found that it did not, and that a single well-delivered active did better. Climbazole holds its place in Europe because zinc pyrithione was prohibited, which is a regulatory fact rather than a finding about this molecule.

Not the same as its namesake

Climbazole belongs to the azole class and is regularly discussed as though that made it a cosmetic version of ketoconazole. It is not, and this card's grades do not extend to ketoconazole. Ketoconazole is a medicine, used at 1 to 2% under medical regulation, with its own body of controlled evidence in seborrhoeic dermatitis. Climbazole is a cosmetic ingredient with a different potency profile and a far thinner independent record. Shared chemical class is not shared evidence.

Identity

Climbazole is a synthetic imidazole antifungal, a single defined molecule rather than a mixture, used in cosmetics as an anti-dandruff active and as a preservative. It is common in European hair care and comparatively uncommon in American anti-dandruff products, for regulatory rather than technical reasons.

Development & history

Climbazole spent decades as a secondary option in a category dominated by zinc pyrithione, most often formulated alongside another active rather than as the sole antifungal in a product.

Its European position changed in 2022, when zinc pyrithione was prohibited in EU cosmetics following its classification as toxic for reproduction, category 1B. The formulators who had relied on it needed replacements carrying no equivalent classification, and climbazole and piroctone olamine were the available candidates. Neither won a contest. Both inherited a market.

The comparative literature that now supports climbazole predates that shift and was designed around different questions, principally how to make a zinc pyrithione shampoo perform better.

Mechanism (as proposed)

Dandruff is associated with Malassezia yeasts on the scalp and the flaking that accompanies their proliferation. Climbazole, like other azoles, is proposed to inhibit fungal cytochrome P450 enzymes involved in ergosterol synthesis, degrading the integrity of the fungal cell membrane.

The mechanism is well characterised for the azole class generally. What it does not resolve is how much suppression this particular molecule achieves at cosmetic concentrations in a product that is rinsed off within minutes, which is the question the trial design has consistently left unanswered by pairing it with something else.

As with every active in this category, the proposal is suppression of the organism rather than any change to why a given scalp reacts to it, so flaking returns when treatment stops.

Related reading

Our comparison of anti-dandruff actives sets these ingredients against each other and explains the regulatory decision that reshaped the European shelf. The companion entries for zinc pyrithione and piroctone olamine carry the detail on each.

Scan your productSee if Climbazole is in what you're usingOpen the scanner →
Sources — 3 cited
01Schmidt-Rose T, Braren S, Fölster H, Hillemann T, Oltrogge B, Philipp P, Weets G, Fey S. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. International Journal of Cosmetic Science. 2011;33(3):276-282. PMID 21272039.
02Turner GA, Matheson JR, Li G-Z, Fei X-Q, Zhu D, Baines FL. Enhanced efficacy and sensory properties of an anti-dandruff shampoo containing zinc pyrithione and climbazole. International Journal of Cosmetic Science. 2012. PMID 22970742.
03Schwartz JR, et al. Therapeutic efficacy of anti-dandruff shampoos: a randomized clinical trial comparing products based on potentiated zinc pyrithione and zinc pyrithione/climbazole. International Journal of Cosmetic Science. 2013. PMID 23614401.
Updated 2026-08-29

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
Piroctone OlamineB
Small molecule (non-peptide)
Zinc PyrithioneB
Small molecule (non-peptide)
Salicylic AcidA
Small molecule (non-peptide)
Explore by goal
Hair & topical →
Vallydia

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

Region — International
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen dataBrands
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.